Clinical trial
Thalidomide for the Treatment of Malnutrition Inflammation Syndrome in…
NCT00390247 · Chinese University of Hong Kong, Other · Withdrawn
Key facts
| NCT number | NCT00390247 |
|---|---|
| Title | Thalidomide for the Treatment of Malnutrition Inflammation Syndrome in Peritoneal Dialysis Patients |
| Official title | Thalidomide for the Treatment of Malnutrition Inflammation Syndrome in Peritoneal Dialysis Patients: A Randomized Control Trial |
| Lead sponsor | Chinese University of Hong Kong, Other |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Peritoneal Dialysis, Malnutrition |
| Intervention type | Drug |
| Interventions | thalidomide |
| Enrollment | 0 |
| Start date | Jan 1, 2007 |
| Completion | Dec 1, 2008 |
| First posted | Oct 19, 2006 |
| Last update posted | Feb 9, 2016 |
| Countries | Hong Kong |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: